Alerts
New BIOSECURE Act Targets Foreign-Linked Biotech
By Jianming Jimmy Hao, Ph.D., Joe Chen, Ph.D., Jonathan R. Lagarenne and Gerard P. Norton, Ph.D.
Publications
Articles
How to Navigate the Biosimilar and Biologic Markets Amid Challenging US Litigation Trends
Intellectual Asset Management
By Gerard P. Norton, Jonathan R. Lagarenne, Jianming Jimmy Hao, Howard S. Suh and Jonathan J. Madara
Articles
Biosimilars and Biologics Litigation in the United States
IAM
By Gerard P. Norton, Ph.D., Jonathan R. Lagarenne, Jianming Jimmy Hao, Ph.D., Howard S. Suh and Jonathan J. Madara
Alerts
Supreme Court Unanimously Affirms Enablement Requirement in Closely Watched Amgen-Sanofi Case
By Jonathan Madara*, Jianming Jimmy Hao, Peter F. Corless and Gerard P. Norton
Articles
Supreme Court's 'Sandoz v. Amgen' Decision Favors Biosimilars
New Jersey Law Journal
By Gerard P. Norton, Ph.D.
Articles
FDA Issues New Draft Guidance on Biosimilars
The National Law Journal
By Gerard P. Norton, Ph.D.
Articles
The Trans-Pacific Partnership Patent Provisions’ Impact on the U.S. Pharmaceutical Industry
Bloomberg BNA
By Gerard P. Norton, Ph.D.
